EU Pharma Overhaul May Reshape Aspects Of Drug Promotion And HCP Partnerships

 
• By Eliza Slawther
  
Companies may need to adjust their drug advertising activities in light of legislative changes at the EU-level (Shutterstock)

More from Marketing & Advertising

More from Europe